Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells

Circulation Research

Volumn 76, Issue 6, 1995, Pages 1101-1108

  Khalil, Raouf A ^a   Menice, Constance B ^a   Wang, C L Albert ^b   Morgan, Kathleen G ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

caldesmon; mitogen activated protein kinase; signal transduction; tyrosine phosphorylation; vascular smooth muscle

Indexed keywords

ALPHA CYANO 3 ETHOXY 4 HYDROXY 5 (PHENYLTHIOMETHYL)CINNAMAMIDE; ALPHA CYANOTHIOCAFFEIC ACID AMIDE; CALDESMON; CALPHOSTIN C; CONTRACTILE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLEPHRINE; PHOSPHOTYROSINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RG 50864 2; STAUROSPORINE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LOCALIZATION; FERRET; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SMOOTH MUSCLE FIBER; THORACIC AORTA;

EID: 0029021180     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.76.6.1101     Document Type: Article

References (38)

1. Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Regulation. 1991;2:965-978.
2. Rossomando AJ, Payne DM, Webber MJ, Sturgill TW. Evidence that pp42, a major tyrosine kinase target protein, is a mitogenactivated serine/threonine kinase. Proc Natl Acad Sci U S A. 1989;86:6940-6943.
3. Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J, Cobb MH. An insulin stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 1990;249:64-67.
4. Chen RH, Sarnecki C, Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol. 1992;12: 915-927.
5. Anderson NG, Maller JL, Tonks NK, Sturgill TW. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 1990;343:651-653.
6. Nel AE, Hanekom C, Rheeder A, Williams K, Pollack S, Katz R, Landreth GE. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. J Immunol. 1990;144:2683-2689.
7. Ferrell JE Jr, Martin GS. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol Cell Biol. 1988;8: 3603-3610.
8. c-src contains a six-amino acid insertion relative to its nonneuronal counterpart. Science. 1987;237:411-415.
9. c-src kinase activity in extracts from vascular smooth muscle. J Biol Chem. 1989;264:10773-10778.
10. Adam LP, Gapinski CJ, Hathaway DR. Phosphorylation sequences in h-caldesmon from phorbol ester-stimulated canine aortas. FEBS Lett. 1992;302:223-226.
11. Childs TJ, Watson MH, Sanghera JS, Campbell DL, Pelech SL, Mak AS. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J Biol Chem. 1992;267: 22853-22859.
12. i. Am J Physiol. 1992;252:H754-H762.
13. 2+-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am J Physiol. 1992;263:C714-C719.
14. Khalil RA, Morgan KG. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle activation. Am J Physiol. 1993;265:C406-C411.
15. DeFeo TT, Morgan KG. Responses of enzymatically isolated mammalian vascular smooth muscle cells to pharmacological and electrical stimuli. Pflugers Arch. 1985;404:100-102.
16. Khanna PL, Ullman EF. 4′,5′-Dimethoxy-6-carboxyfluorescein: a novel dipole-dipole coupled fluorescence energy transfer acceptor useful for fluorescence immunoassays. Anal Biochem. 1980;108: 156-161.
17. Agard DA, Hiraoka Y, Shaw P, Sedat JW. Fluorescence microscopy in three dimensions. In: Taylor DL, Wang Y, eds. Fluorescence Microscopy of Living Cells in Culture. New York, NY: Academic Press Inc; 1989:353-377.
18. Khalil RA, Morgan KG. Imaging of protein kinase C distribution and translocation in living vascular smooth muscle cells. Circ Res. 1991;69:1626-1631.
19. Khalil RA, Morgan KG. Phenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret. J Physiol (Lond). 1992;455:585-599.
20. 2+]i threshold for translocation of the α-protein kinase C isoform. Am J Physiol. 1994;266:C1544-C1551.
21. Godt RE, Kirby AC, Gordon AM. Effects of hypertonic solutions on contraction of frog tonic muscle fibers. Am J Physiol. 1984;246: C148-C153.
22. Cecchi G, Bagni MA. Myofilament lattice spacing affects tension in striated muscle. News Physiol Sci. 1994;9:3-7.
23. Parker CA, Takahashi K, Tao T, Morgan KG. Agonist-induced redistribution of calponin in contractile vascular smooth muscle cells. Am J Physiol. 1994;267:C1262-C1270.
24. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548-553.
25. Hidaka H, Hagiwara H. Pharmacology of the isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase C. Trends Pharmacol Sci. 1987;8:162-164.
26. Yaish P, Gazit A, Gilon C, Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science. 1988;242:933-935.
27. Lyall RM, Zilberstein A, Gazit A, Gilon C, Levitzki A, Schlessinger J. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem. 1989;264:14503-14509.
28. Shiraishi T, Owada K, Tatsuka M, Yamashita T, Watanabe K, Kakunaga T. Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamide derivatives in vitro. Cancer Res. 1989;49:2374-2378.
29. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun. 1993;190: 968-974.
30. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science. 1991;252:668-674.
31. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. Oncogenes and signal transduction. Cell. 1991;64:281-302.
32. mapkk) in fibroblasts. J Cell Biol. 1993;122:1079-1088.
33. Gonzalez FA, Seth A, Raden DL, Bowman DS, Fay FS, Davis RJ. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol. 1993;122:1089-1101.
34. Sobue K, Sellers JR. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem. 1991;266:12115-12118.
35. Wang C-LA, Wang L-WC, Xu S, Lu RC, Saavedra-Alanis V, Bryan J. Localization of the calmodulin- and the actin-binding sites of caldesmon. J Biol Chem. 1991;266:9166-9172.
36. Katsuyama H, Wang C-LA, Morgan KG. Regulation of vascular smooth muscle tone by caldesmon. J Biol Chem. 1992;267: 14555-14558.
37. North AJ, Gimona M, Cross RA, Small JV. Calponin is localized in both the contractile apparatus and the cytoskeleton of smooth muscle cells. J Cell Sci. 1994;107:437-444.
38. Adam LP, Haeberle JR, Hathaway DR. Phosphorylation of caldesmon in arterial smooth muscle. J Biol Chem. 1989;264: 7698-7703.